Overview
TrakCel provides OCELLOS, a Salesforce-powered cellular orchestration platform for managing cell and gene therapies from clinical trials to commercialization. It ensures chain of identity, chain of custody, visibility, and auditing across patient enrollment, sample collection, manufacturing, logistics, and treatment delivery. The solution supports autologous, allogeneic, and personalized therapies, enabling real-time control and scalability for global operations.
Frequently asked questions
- What capabilities does OCELLOS provide for cell and gene therapy supply chains?
- OCELLOS offers end-to-end orchestration including patient enrollment, sample collection, manufacturing, logistics, and treatment, with real-time visibility, chain of identity/custody, and audit trails for autologous, allogeneic, and personalized therapies.
- What regulatory compliance features does TrakCel support?
- OCELLOS safeguards chain of custody (COC), chain of identity (COI), and full audit trails to ensure compliance, traceability, and efficiency across the therapy value chain.
- In which geographies does TrakCel operate?
- TrakCel is headquartered in Cardiff, UK, with offices in the US, supporting global scale-up of cell and gene therapies.